Fisetin protects the heart against ischemia-reperfusion injury and the evident cardioprotection is PPAR-γ dependant. In conclusion, this study has revealed a prime mechanism involved in the cardioprotective effects of fisetin. Hence, Fisetin may be evaluated in further clinical studies as a cardioprotective agent in patients undergoing reperfusion interventions.
“a lot more balls in its court” as research comes to light. Possibly an exciting supplement.
Out with the anecdotes!!
See my forum post here. Cheers.
NMN - Daily - Starting dose 2019/12 tabs @ 500mg, 2020/04 tabs @ 1g, 2020/06 LSG @ 1g.
NAD+ - Daily - Starting dose 2020/09 LSG @ 250mg.